Thrombosis;
Anticoagulation;
Laboratory assay;
DIRECT THROMBIN INHIBITOR;
FACTOR XA INHIBITOR;
COAGULATION ASSAYS;
DABIGATRAN ETEXILATE;
RIVAROXABAN;
TIME;
PLASMA;
D O I:
10.1016/j.thromres.2012.08.288
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
New oral anticoagulants are ready to enter the scene on a massive basis for the treatment/prophylaxis of many cardiovascular diseases. Although they can be prescribed without dose-adjustment based on laboratory testing, the laboratory is still an essential partner that may assist clinicians for the management of anticoagulated patients. In principle, there are many tests that can be used to evaluate the anticoagulant effect of the new drugs, but the choice should be made among those that are more readily available in emergency and that are easy to run. Linearity of dose-response and responsiveness to increasing dose in addition to standardization are other important issues to consider. This article is aimed at reviewing the current tests, their characteristics and the most appropriate choice. (C) 2012 Elsevier Ltd. All rights reserved.
机构:
Univ St Etienne, Grp Rech Thrombose, EA CIE3 3065, Unite Rech Clin Pharmacol,CHU St Etienne, St Etienne, FranceUniv Paris 05, INSERM U765, Paris, France
Mismetti, Patrick
Flaujac, Claire
论文数: 0引用数: 0
h-index: 0
机构:
Hop Hotel Dieu, Hematol Lab, F-75181 Paris, FranceUniv Paris 05, INSERM U765, Paris, France
Flaujac, Claire
Delavenne, Xavier
论文数: 0引用数: 0
h-index: 0
机构:
Univ St Etienne, Grp Rech Thrombose, EA CIE3 3065, Unite Rech Clin Pharmacol,CHU St Etienne, St Etienne, FranceUniv Paris 05, INSERM U765, Paris, France
Delavenne, Xavier
Laporte, Silvy
论文数: 0引用数: 0
h-index: 0
机构:
Univ St Etienne, Grp Rech Thrombose, EA CIE3 3065, Unite Rech Clin Pharmacol,CHU St Etienne, St Etienne, FranceUniv Paris 05, INSERM U765, Paris, France
Laporte, Silvy
论文数: 引用数:
h-index:
机构:
Loriot, Marie-Anne
Lecompte, Thomas
论文数: 0引用数: 0
h-index: 0
机构:
Nancy Univ, CHU Nancy, Serv Hematol Biol, Inserm U961, Nancy, FranceUniv Paris 05, INSERM U765, Paris, France